Jennifer R Wang, MD PhD

Head and Neck Surgeon, Associate Professor @MDAndersonNews. #genomics research on #thyroidcancer #headandneckcancer. Views are my own

[Jennifer R Wang, MD PhD @JenniferWangMD]

Excited to finally share a preview of our work recently accepted @jclinicalinvest dissecting the evolutionary spectrum of thyroid cancer from papillary to anaplastic thyroid cancer using single-cell and bulk sequencing https://t.co/lUSMDginYS

[Ahmad Abubaker, MD @A_AbubakerMD]

A big thank you for Dr @JenniferWangMD & Dr @DrMCabanillas for their efforts to held the ATC research retreat today @MDAndersonNews
In the picture is Dr @DrAManiakas presenting our current advancements in PDX models as well as future directions in ATC translational efforts

[Jennifer R Wang, MD PhD @JenniferWangMD]

Catching up with the extended @UofT_OHNS @MSKCancerCenter fam at Current Concepts in Head and Neck Oncology #MSKHeadNeckCME

[Aatish Thennavan @ThennavanAatish]

It was such a great experience at #ATA2024. Got to showcase the amazing collaborative science we do at @MDAndersonNews. Huge thanks to @nicholas_navin @JenniferWangMD, Dr.Xiao Zhao and the whole head & neck cancer team!

[Jennifer R Wang, MD PhD @JenniferWangMD]

@SophieLi1569

[Jennifer R Wang, MD PhD @JenniferWangMD]

So proud of @ThennavanAatish and @sophieli0224 who both received outstanding trainee awards for presenting their work on thyroid cancer genomics at #ATA2024

[Jennifer R Wang, MD PhD @JenniferWangMD]

Dr. Sarah Hamidi presenting our multidisciplinary study on thyroid differentiation score as a determinant of immune infiltration and potential therapeutic targets in papillary thyroid cancer #ata2024 #cancerhistory #thyroidcancer @DrMCabanillas @WenyiWang4 @MarkZafereoMD

[UT MD Anderson @UTMDAnderson]

Judd Woehrle recalls the support and compassion he received at MD Anderson throughout his treatment.

“They kept me informed, and I never had to worry about the planning.” https://t.co/A1Muld2gjW @JenniferWangMD @AnnaLeeMDMPH #EndCancer

[Thyroid Journal @thyroidjournal]

Check out this new exciting article in @ThyroidJournal: Authors at @MDAndersonNews introduce a novel treatment algorithm for #Anaplastic Thyroid Cancer with significant effect on Survival.

https://t.co/BCYkRSW1AN

#ThyroidCancer @MarkZafereoMD @JenniferWangMD @DrMCabanillas

[Jennifer R Wang, MD PhD @JenniferWangMD]

Hi-lighting the need to further study how germline variations impact somatic tumor phenotype in this highly heritable cancer type @EndoSocJournals

[Jennifer R Wang, MD PhD @JenniferWangMD]

Check out our paper featured this week in #JCEM showing that higher germline genetic risk in papillary thyroid cancer, estimated using a polygenic risk score, is associated with higher odds of having a BRAF-mutated tumor
https://t.co/pQoVjikZsU.

[Peter Van Loo @VanLooLab]

Exciting find in our #OralCancer study! 🧬 Brush biopsies prove promising, reflecting 90% of somatic changes vs. tissue biopsies. 🩸 Highlighting their potential in understanding tumor evolution. #CancerEvolution https://t.co/5kkXUrHyRj

[Jennifer R Wang, MD PhD @JenniferWangMD]

Wonderful time @ThyCaInc celebrating our patients and a decade of progress in anaplastic #thyroidcancer @DrMCabanillas @naifa_busaidy @MarkZafereoMD truly inspirational to see so many of our ATC survivors with their families all in one place!

[American Thyroid Association @AmThyroidAssn]

The secret is out!

Congratulations on this well-deserved award, @MarkZafereoMD.

[Jennifer R Wang, MD PhD @JenniferWangMD]

So proud of Meghan Kisiel from my lab on an excellent presentation @ahnsinfo on our collaborative work with @DrXiaoZhao @nicholas_navin @ThennavanAatish describing genetic/functional evolution of BRAF anaplastic #thyroidcancer using a next-gen mouse model

[Jennifer R Wang, MD PhD @JenniferWangMD]

Congratulations to our newly graduated fellow Dr. Albert Han on winning 🥇 prize at the @ahnsinfo poster competition examining expression differences in dedifferentiated BRAF-mutated papillary #thyroidcancer Awesome work! @MDAndersonNews

[Jennifer R Wang, MD PhD @JenniferWangMD]

@DrDebashreeRay @NIH @jhugeneticepi Congrats Debashree!!! Amazing news

[Vivek Subbiah, MD @VivekSubbiah]

🚨Thrilled to present to the world today -->A new drug for patients with #chondrosarcoma
Hot off the press for @ASCO #ASCO23 @C@CCR_AACR
-->Preclinical Characterization and Phase 1 Trial Results of INBRX-109, a Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma
Thankful to all patients, caregivers & all co-investigators #rarecancer
https://t.co/YsE2UfBxoE @OncBrothers @bvantine1 @OncoAlert

[Medical Xpress @medical_xpress]

Understanding how aggressive #thyroidcancer evolves @northwesternu @jclinicalinvest https://t.co/pkGs3IReUK https://t.co/oemtqF1u3d

[UT MD Anderson @UTMDAnderson]

From a combination therapy for acute lymphoblastic leukemia to new insights into anaplastic thyroid cancer to a promising new treatment approach for pancreatic cancer, learn about the latest advances: https://t.co/Mjs8IJaXh6 @DrHKantarjian @JenniferWangMD @Dr_Di_Zhao #EndCancer

[Jennifer R Wang, MD PhD @JenniferWangMD]

Team science at its best @MDAndersonNews

[Jennifer R Wang, MD PhD @JenniferWangMD]

Excited to finally share a preview of our work recently accepted @jclinicalinvest dissecting the evolutionary spectrum of thyroid cancer from papillary to anaplastic thyroid cancer using single-cell and bulk sequencing https://t.co/lUSMDginYS

[Jennifer R Wang, MD PhD @JenniferWangMD]

This work was a labor of love many years in the works as we learned that ATC tumors are very difficult to dissociate 😩